Paper I
2024 June (Supplementary) (2019 Scheme) · 100 marks · 180 min

Question

Pharmacological basis for the use of Timolol in glaucoma.

Q104 marksShort Answers

Answer

Aqueous humour is continuously formed by the ciliary epithelium through a beta-adrenergic-receptor-driven, cAMP-mediated secretory process. Timolol, a non-selective beta-blocker, blocks these beta receptors on the ciliary epithelium, reducing cAMP-mediated aqueous humour production and thereby lowering intraocular pressure. Given topically as an eye-drop, systemic absorption is low at ocular doses, though not negligible — systemic contraindications (bronchial asthma, heart block, bradycardia) still apply despite the local route of administration.

Other Years Asked


Revise MBBS
Preview